Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Dec 16, 2014; 2(12): 828-834
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.828
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.828
Table 2 Prevalence of obstructive sleep apnoea in interstitial lung disease populations n (%)
Ref. | Population | Prevalence of OSA | M/F | Age (mean) | BMI(mean) | Comment |
Aydoğdu et al[18], 2006 | ILD | 24 (65) | Abstract only | |||
Mermigkis et al[17], 2007 | IPF | 11 (61) | 12/6 | 68.1 | 33.2 | Retrospective study; subjects with symptoms of SDB |
Lancaster et al[19], 2009 | IPF | 44 (88) | 34/16 | 65.7 | 32.2 | Prospective study of unselected patients; 16 subjects used oxygen during PSG |
Mermigkis et al[20], 2010 | IPF | 20 (59) | 21/13 | 65.0 | 27.3 | Prospective study of subjects with newly diagnosed IPF |
Kolilekas et al[2], 2013 | IPF | 28 (90) | 24/7 | 68.0 | 28.7 | Increased AHI associated with decreased survival, after exclusion of those prescribed CPAP |
Pihtili et al[25], 2013 | ILD | 34 (68) | 14/36 | 53.9 | 25.9 | Prospective study; excluded obese subjects (BMI ≥ 30) |
IPF | 14 (82) | |||||
Sarcoidosis | 10 (67) | |||||
Scleroderma | 10 (56) |
- Citation: Troy LK, Corte TJ. Sleep disordered breathing in interstitial lung disease: A review. World J Clin Cases 2014; 2(12): 828-834
- URL: https://www.wjgnet.com/2307-8960/full/v2/i12/828.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i12.828